Pfizer for Professionals Pfizer for Professionals




Pfizer Medical Information
(Search Medical Responses)
WyethHCP.com
(Access Wyeth for Professionals)
Explore Other Online Resources
ppn-vr-sso-links.htm
To report an adverse event or to speak to a member of Pfizer Medical Information, please call 1-800-438-1985

Share Your Feedback
Prescribing Information
NORVASC® (amlodipine besylate) Tablets
Indications and Usage
Return to the NORVASC Product Center

1. Hypertension
NORVASC is indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents.

2. Coronary Artery Disease (CAD)
Chronic Stable Angina
NORVASC is indicated for the symptomatic treatment of chronic stable angina. NORVASC may be used alone or in combination with other antianginal agents.

Vasospastic Angina (Prinzmetal's or Variant Angina)
NORVASC is indicated for the treatment of confirmed or suspected vasospastic angina. NORVASC may be used as monotherapy or in combination with other antianginal drugs.

Angiographically Documented CAD
In patients with recently documented CAD by angiography and without heart failure or an ejection fraction <40%, NORVASC is indicated to reduce the risk of hospitalization due to angina and to reduce the risk of a coronary revascularization procedure.


NORVASC Safety Information
 

Important Safety Information

NORVASC is indicated for the treatment of hypertension and angina.

In clinical trials, the most common side effects versus placebo were edema (8.3% vs 2.4%), headache (7.3% vs 7.8%), fatigue (4.5% vs 2.8%), and dizziness (3.2% vs 3.4%).

Generally CCBs should be used with caution in patients with heart failure. In studies with NORVASC, there has been no evidence of worsened heart failure.

 

Please see full prescribing information.

NORVASC ® (amlodipine besylate)

Back to Top

SetPProProdListVar.htm
SetPFPGroupVar.htm